Evidence map›Paper›PMID 42579862›Full record

ArticleJournal of clinical psychology2026

Examining the Directional Effects of Insomnia, Anxiety, and Depression Symptoms: Results From a Longitudinal Study Conducted During the COVID-19 Pandemic.

Jamie Walker, Ana J Bridges, Alexandria Muench, Michael L Perlis, Ivan Vargas

Abstract read
In one paragraph

Article in Journal of clinical psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jamie WalkerDepartment of Psychological Science, University of Arkansas, Fayetteville, Arkansas, USA.ORCID https://orcid.org/0000-0003-2256-3931
Ana J BridgesDepartment of Psychological Science, University of Arkansas, Fayetteville, Arkansas, USA.ORCID https://orcid.org/0000-0001-9836-9946
Alexandria MuenchBehavioral Sleep Medicine Program, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-4826-8498
Michael L PerlisBehavioral Sleep Medicine Program, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ivan VargasDepartment of Psychology, University of Notre Dame, Notre Dame, Indiana, USA.ORCID https://orcid.org/0000-0002-0787-5630

Funding

Behavioral Sleep Medicine: Training in Sleep and AgingK24AG055602 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Michael Lloyd Perlis · 2017 to 2026
$1.6M
Circadian and Ultradian Cortisol Rhythms in Chronic Sleep Continuity DisturbanceK23HL141581 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI VARGAS, IVAN · 2019 to 2023
$677k
NHLBI NIH HHS K23 HL141581NIA NIH HHS K24 AG055602NIH HHS K23HL141581NIH HHS K24AG055602
6 · The paper itself

Abstract

objectivesWhile some research suggests that increases in anxiety symptoms drive changes in insomnia and depression symptoms, other studies support that these relations may be bidirectional. The present study therefore aimed to further examine how anxiety, insomnia and depression symptoms predict changes in these symptoms over time.

methodsParticipants were recruited via an online participant database, social media advertisements, and other online sites, resulting in a large sample (N = 2,666) of adults from across the United States. Well validated instruments were used to measure symptoms of depression (CES-D), anxiety (STAI), and insomnia (ISI). Data were collected via a series of Qualtrics surveys administered online at two time points: March-June 2020 (baseline) and January-March 2021 (follow-up).

resultsInsomnia symptoms (β = 0.142, p < 0.001) but not anxiety symptoms (β = 0.019, p = 0.445) significantly predicted depression symptoms. Depression symptoms (β = 0.077, p = 0.001) but not anxiety symptoms (β = 0.039, p = 0.075) significantly predicted insomnia symptoms. Both insomnia (β = 0.060, p = 0.001) and depression symptoms (β = 0.281, p < 0.001) significantly predicted anxiety symptoms. Although multiple cross-lagged paths were statistically significant, effect sizes were generally small, and no single pathway was meaningfully stronger than others. Additionally, secondary exploratory mediation models revealed significant indirect effects between anxiety and depression through insomnia (model 1 indirect β = 0.027, p = 0.007; model 2 indirect β = 0.008, p = 0.036).

conclusionsFindings suggest that insomnia symptoms were prospectively associated with subsequent depressive and anxiety symptoms. Depression symptoms also predicted later anxiety symptoms, highlighting the complex longitudinal associations among these symptom domains. However, results did not support a temporal pathway in which anxiety precedes the development of comorbid insomnia. Future studies should assess temporal order more closely, using high density longitudinal sampling strategies (i.e., more than two data collection points) to further clarify the temporal ordering of these symptom domains.

Indexed as

AnxietyCOVID-19DepressionSleep Initiation and Maintenance DisordersAdultFemaleHumansLongitudinal StudiesMaleMiddle AgedUnited StatesYoung AdultanxietyCOVID‐19depressioninsomnia

Identifiers

PMID42579862
PMCPMC13630351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.